Trial intelligence / Profile preview

Aliskiren and Vitamin D in Hypertension

NCT00974922Phase 4Terminated

Sponsor
UConn Health
Start
Aug 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aliskiren in hypertension (HTN), sponsored by UConn Health. Started Aug 2009; status: terminated.

02

Drugs

aliskiren
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00974922.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00974922.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call